Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Covington
Argus Health
Chinese Patent Office
Harvard Business School
Baxter
Daiichi Sankyo
Fuji
McKinsey

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076490

« Back to Dashboard

NDA 076490 describes LITHIUM CARBONATE, which is a drug marketed by Able, Alembic Ltd, Apotex Inc, Glenmark Generics, Hetero Labs Ltd Iii, Mylan Pharms Inc, Usl Pharma, Watson Labs, West-ward Pharms Int, Alembic Pharms Ltd, Barr, Glenmark Pharms Inc, Heritage Pharma, Hikma Intl Pharms, Unique Pharm Labs, Pfizer, and Sun Pharm Inds Inc, and is included in twenty-nine NDAs. It is available from thirty-four suppliers. Additional details are available on the LITHIUM CARBONATE profile page.

The generic ingredient in LITHIUM CARBONATE is lithium carbonate. There are fifteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.
Summary for 076490
Tradename:LITHIUM CARBONATE
Applicant:Hikma Intl Pharms
Ingredient:lithium carbonate
Patents:0
Therapeutic Class:Bipolar Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 076490
Medical Subject Heading (MeSH) Categories for 076490
Suppliers and Packaging for NDA: 076490
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 076490 ANDA West-Ward Pharmaceutical Corp 0143-1277 0143-1277-01 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0143-1277-01)
LITHIUM CARBONATE lithium carbonate TABLET, EXTENDED RELEASE;ORAL 076490 ANDA Physicians Total Care, Inc. 54868-5340 54868-5340-0 60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (54868-5340-0)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength450MG
Approval Date:Jun 17, 2003TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
McKesson
Chubb
Mallinckrodt
Daiichi Sankyo
Chinese Patent Office
Dow
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot